Middle East and Africa Metastatic Cancer Drugs Market Forecast to 2028

Report Code : BMIRE00025360 | Region : LAMEA | Industry : Pharmaceuticals | Published Date : 15/Jul/2022
Middle East and Africa Metastatic Cancer Drugs Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Cancer Type (Breast Cancer, Lung Cancer, Liver Cancer, Hematological Cancer, Brain Cancer, Prostate Cancer, Pancreatic Cancer, and Others), Route of Administration (Intravenous and Intramuscular), Drug Class (HER2 Inhibitors, Immune Checkpoint Inhibitors, PARP Inhibitors, Kinase Inhibitors, and Others), Product (Branded, Generics, and Biosimilars), and End User (Hospital, Specialty Clinic, and Others)

The Middle East and Africa metastatic cancer drugs market is expected to reach US$ 4,087.30 million by 2028 from US$ 3,309.92 million in 2021; it is estimated to grow at a CAGR of 3.1% from 2021 to 2028.

The market is characterized by the presence of big and small companies. To increase their market share, players are adopting many strategies such as product launches, regional expansions, and technological advancements. For instance, in 2020, Duke Cancer Institute launched a proof-of-concept clinical trial of a new drug for hormone receptor-positive breast cancer patients, whose disease has spread to bones. The investigational therapy—GMI-1359—targets both E-selection and CXCR4, normal inflammatory molecules that appear to play a role in tumor trafficking and metastasis to the bone. Continuous innovations and technological advancements are resulting in the introduction of safe and effective metastatic cancer drugs, leading to increased acceptance among patients and medical societies.Such factor of new startegies by various companies are increasing the market growth of metastatic cancer drugs.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the metastatic cancer drugs market growth in the coming years. The market is expected to grow at a good CAGR during the forecast period.

Middle East and Africa Metastatic Cancer Drugs Market Revenue and Forecast to 2028 (US$ Million)

Middle East and Africa Metastatic Cancer Drugs Market Segmentation

The market for Middle East and Africa metastatic cancer drugs market is segmented into cancer type , route of administration , drug class , product , and end user. Based on cancer type , the market is segmented into breast cancer, lung cancer, liver cancer, haematological cancer, brain cancer, prostate cancer, pancreatic cancer, and others. Based on route of administration, the market is bifurcated into intravenous and intramuscular. Based on drug class, the Middle East and Africa metastatic cancer drugs market is segmented into HER2 inhibitors, immune checkpoint inhibitors, parp inhibitors, kinase inhibitors, and others. Based on product, the market is segmented into branded, generics, and biosimilars. Based on end user, the market is segmented into hospital, specialty clinic, and others. By country, the Middle East and Africa metastatic cancer drugs market is segmented into Saudi Arabia , South Africa , the UAE, and Rest of Middle East and Africa.

Middle East and Africa Metastatic Cancer Drugs Market – Companies Mentioned

AbbVie Inc.; Amgen Inc. ; Bristol-Myers Squibb Company ; F. HOFFMANN-LA ROCHE LTD.; Novartis AG ; Astrazeneca ; MERCK KGaA ; Pfizer Inc. (Arena Pharmaceutical GmbH) ; and Johnson and Johnson Services, Inc. are among the leading companies in the Middle East and Africa metastatic cancer drugs market.

The List of Companies - Middle East and Africa Metastatic Cancer Drugs Market

● AbbVie Inc.                                                                                                        

● Amgen Inc.                                                                                                         

● Bristol-Myers Squibb Company                                                                 

● F. HOFFMANN-LA ROCHE LTD.                                                                   

● Novartis AG                                                                                                       

● Astrazeneca                                                                                                      

● MERCK KGaA                                                                                                    

● Pfizer Inc. (Arena Pharmaceutical GmbH)                                             

● Johnson and Johnson Services, Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East and Africa Metastatic Cancer Drugs Market – By Cancer Type

1.3.2 Middle East and Africa Metastatic Cancer Drugs Market – By Route of Administration

1.3.3 Middle East and Africa Metastatic Cancer Drugs Market – By Drug Class

1.3.4 Middle East and Africa Metastatic Cancer Drugs Market – By Product

1.3.5 Middle East and Africa Metastatic Cancer Drugs Market – By End User

1.3.6 Middle East and Africa Metastatic Cancer Drugs Market – By Country

2. Middle East and Africa Metastatic Cancer Drugs Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East and Africa Metastatic Cancer Drugs Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Middle East and Africa– PEST Analysis

4.3 Expert Opinion

5. Middle East and Africa Metastatic Cancer Drugs Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 High Prevalence of Metastatic Cancer

5.1.2 Government Initiatives to Support Developments in Cancer Treatment

5.2 Market Restraints

5.2.1 High Cost of Oncology Drugs

5.3 Market Opportunities

5.3.1 Investments in Artificial Intelligence for Oncology Drug Development

5.4 Future Trends

5.4.1 Increase in Launch of Metastatic Cancer Drugs

5.5 Impact analysis

6. Middle East and Africa Metastatic Cancer Drugs Market –Country Analysis

6.1 Middle East and Africa Metastatic Cancer Drugs Market Revenue Forecast and Analysis

6.1.1 Middle East and Africa : Middle East and Africa Metastatic Cancer Drug Market - Revenue and Forecasts to 2028, (US$ Mn)

7. Middle East and Africa Metastatic Cancer Drug Market Analysis – By Cancer Type

7.1 Overview

7.2 Middle East and Africa Metastatic Cancer Drug Market Revenue Share, by Cancer Type (2021 and 2028)

7.2.1 Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

7.3 Breast Cancer

7.3.1 Overview

7.3.2 Breast Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Lung Cancer

7.4.1 Overview

7.4.2 Lung Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Liver Cancer

7.5.1 Overview

7.5.2 Liver Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Hematological Cancer

7.6.1 Overview

7.6.2 Haematological Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Brain Cancer

7.7.1 Overview

7.7.2 Brain Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Prostate Cancer

7.8.1 Overview

7.8.2 Prostate Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.9 Pancreatic Cancer

7.9.1 Overview

7.9.2 Pancreatic Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.10 Others

7.10.1 Overview

7.10.2 Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

8. Middle East and Africa Metastatic Cancer Drug Market – By Route of Administration

8.1 Overview

8.2 Middle East and Africa Metastatic Cancer Drug Market, by Route of Administration, 2021 and 2028 (%)

8.2.1 Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

8.3 Intravenous

8.3.1 Overview

8.3.2 Intravenous: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Intramuscular

8.4.1 Overview

8.4.2 Intramuscular: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Oral

8.5.1 Overview

8.5.2 Oral: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East and Africa Metastatic Cancer Drug Market – By Drug Class

9.1 Overview

9.2 Middle East and Africa Metastatic Cancer Drug Market, by Drug Class, 2021 and 2028 (%)

9.2.1 Middle East & Africa Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)

9.3 HER2 Inhibitors

9.3.1 Overview

9.3.2 HER2 Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Immune Checkpoints Inhibitors

9.4.1 Overview

9.4.2 Immune Checkpoints Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.5 PARP Inhibitors

9.5.1 Overview

9.5.2 PARP Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Kinase Inhibitors

9.6.1 Overview

9.6.2 Kinase Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East and Africa Metastatic Cancer Drug Market – By Product

10.1 Overview

10.2 Middle East and Africa Metastatic Cancer Drug Market, by Product, 2021 and 2028 (%)

10.2.1 Middle East & Africa Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

10.3 Branded

10.3.1 Overview

10.3.2 Branded: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Generics and Biosimilars

10.4.1 Overview

10.4.2 Generics and Biosimilars: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

11. Middle East and Africa Metastatic Cancer Drug Market – By End User

11.1 Overview

11.2 Middle East and Africa Metastatic Cancer Drug Market, by End User, 2021 and 2028 (%)

11.2.1 Middle East & Africa: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

11.3 Hospital

11.3.1 Overview

11.3.2 Hospitals: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

11.4 Specialty Clinic

11.4.1 Overview

11.4.2 Specialty Clinics: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

11.5 Others

11.5.1 Overview

11.5.2 Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

12. Middle East and Africa Metastatic Cancer Drugs Market – Regional Analysis

12.1 Middle East and Africa: Metastatic Cancer Drugs Market

12.1.1 Overview

12.1.2 Middle East & Africa: Metastatic Cancer Drug Market, by Country, 2021 & 2028 (%)

12.1.2.1 Saudi Arabia: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)

12.1.2.1.1 Saudi Arabia: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.2 Saudi Arabia Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

12.1.2.1.3 Saudi Arabia Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

12.1.2.1.4 Saudi Arabia Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)

12.1.2.1.5 Saudi Arabia Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

12.1.2.1.6 Saudi Arabia: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

12.1.2.2 UAE: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.1 UAE: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.2 UAE Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

12.1.2.2.3 UAE Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

12.1.2.2.4 UAE Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)

12.1.2.2.5 UAE Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

12.1.2.2.6 UAE: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

12.1.2.3 South Africa: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.1 South Africa: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.2 South Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

12.1.2.3.3 South Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

12.1.2.3.4 South Africa Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)

12.1.2.3.5 South Africa Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

12.1.2.3.6 South Africa: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

12.1.2.4 Rest of Middle East and Africa: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)

12.1.2.4.1 Rest of Middle East and Africa: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)

12.1.2.4.2 Rest of Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

12.1.2.4.3 Rest of Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

12.1.2.4.4 Rest of Middle East & Africa Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)

12.1.2.4.5 Rest of Middle East & Africa Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

12.1.2.4.6 Rest of Middle East & Africa: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

13. Middle East and Africa Metastatic Cancer Drug Market –Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market, 2021-2028

13.3 Inorganic Developments

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 AbbVie Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Amgen Inc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Bristol-Myers Squibb Company

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 F. HOFFMANN-LA ROCHE LTD.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Novartis AG

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Astrazeneca

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 MERCK KGaA

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Pfizer Inc. (Arena Pharmaceutical GmbH)

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Johnson and Johnson Services, Inc.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES.

Table 1. Middle East and Africa: Middle East and Africa Metastatic Cancer Drug Market - Revenue and Forecasts to 2028, (US$ Mn).

Table 2. Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 3. Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 4. Middle East & Africa Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 5. Middle East & Africa Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 6. Middle East & Africa Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7. Saudi Arabia Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 8. Saudi Arabia Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 9. Saudi Arabia Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 10.   Saudi Arabia Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 11.   Saudi Arabia Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12.   UAE Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 13.   UAE Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.   UAE Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 15.   UAE Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 16.   UAE Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17.   South Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 18.   South Africa Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 19.   South Africa Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 20.   South Africa Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 21.   South Africa Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 22.   Rest of Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 23.   Rest of Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 24.   Rest of Middle East & Africa Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 25.   Rest of Middle East & Africa Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 26.   Rest of Middle East & Africa Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 27.   Recent Inorganic Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market

Table 28.   Recent Organic Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market

Table 29.   Glossary of Terms, Middle East and Africa Metastatic Cancer Drugs Market

The List of Companies - Middle East and Africa Metastatic Cancer Drugs Market

● AbbVie Inc.                                                                                                        

● Amgen Inc.                                                                                                         

● Bristol-Myers Squibb Company                                                                 

● F. HOFFMANN-LA ROCHE LTD.                                                                   

● Novartis AG                                                                                                       

● Astrazeneca                                                                                                      

● MERCK KGaA                                                                                                    

● Pfizer Inc. (Arena Pharmaceutical GmbH)                                             

● Johnson and Johnson Services, Inc.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East and Africa Metastatic Cancer Drugs Market.

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in Middle East and Africa Metastatic Cancer Drugs Market, thereby allowing players across the value chain to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth Middle East and Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Middle East and Africa Metastatic Cancer Drugs Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry